Search research articles
Contact Us
Filters
Showing results (381-390 of 399) with videos related to
Page
of 40
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy
R A Beveridge, J A Miller, A N Kales, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Brain-wide neuronal circuit connectome of human glioblastoma
Yusha Sun, Xin Wang, Daniel Y Zhang, et al.
The Journal of Infectious Diseases
|
October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome
Raquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Scientific Data
|
July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
Spyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
ACS Central Science
|
June 30, 2025
Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor
Robert P Sparks, William Lawless, Anna Kharitonova, et al.
Nature Medicine
|
March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Stephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.
Nature Cancer
|
January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
PLOS Global Public Health
|
March 27, 2026
COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics
Chinedu A Ugwu, Ooreofe Odebode, Israel O Ajayi, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity
Oriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 399) with videos related to
Sort By:
Page
of 40
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 1, 1997
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy
R A Beveridge, J A Miller, A N Kales, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2024
Brain-wide neuronal circuit connectome of human glioblastoma
Yusha Sun, Xin Wang, Daniel Y Zhang, et al.
The Journal of Infectious Diseases
|
October 31, 2022
SARS-CoV-2 Serosurveys: How Antigen, Isotype and Threshold Choices Affect the Outcome
Raquel A Binder, Gavin F Fujimori, Catherine S Forconi, et al.
Scientific Data
|
July 29, 2022
The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics
Spyridon Bakas, Chiharu Sako, Hamed Akbari, et al.
ACS Central Science
|
June 30, 2025
Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor
Robert P Sparks, William Lawless, Anna Kharitonova, et al.
Nature Medicine
|
March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Stephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.
Nature Cancer
|
January 12, 2024
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen J Bagley, Zev A Binder, Lamia Lamrani, et al.
Nature Medicine
|
June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial
Stephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
PLOS Global Public Health
|
March 27, 2026
COVID19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics
Chinedu A Ugwu, Ooreofe Odebode, Israel O Ajayi, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity
Oriana Y Teran Pumar, Elton L VanNoy, Abigail Haffey, et al.
Page
of 40